Article ID Journal Published Year Pages File Type
8780171 Gynecologic Oncology 2018 7 Pages PDF
Abstract
The four-marker panel, CA125, HE4, E-CAD, and IL-6, shows potential in detecting serous ovarian cancer at earlier stages. Additional validation studies using the biomarker combination in ovarian cancer patients are warranted.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
Authors
, , , , , , , , , , , , , ,